Key facts
- Notable investors include Thematic Technology Transfer.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Magecmo
- ·The full record, as it builds
Funding rounds
No funding rounds for Magecmo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Magecmo
Developer of extracorporeal circulatory support devices designed for temporary cardiopulmonary assistance in severe heart or lung failure cases. The company develops a magnetic low-shear blood pumping system designed to be integrated into extracorporeal membrane oxygenation setups, with a focus on contactless blood handling, reduced mechanical stress on blood components, and compatibility with standard clinical workflows, enabling hospitals and intensive care units to provide controlled extracorporeal support while seeking to limit device-related complications.
- Sector
- Healthcare
- HQ
- Enschede, Netherlands
- Ownership
- Privately Held (backing)
Magecmo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Magecmo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Magecmo in its N-PORT filings yet. We sweep new filings monthly.